CARDIAC TRANSPLANT
Clinical trials for CARDIAC TRANSPLANT explained in plain language.
Never miss a new study
Get alerted when new CARDIAC TRANSPLANT trials appear
Sign up with your email to follow new studies for CARDIAC TRANSPLANT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Heart transplant hope: drug may clear antibody barriers
Disease control ENROLLING_BY_INVITATIONThis study tests whether the drug daratumumab can lower high levels of HLA antibodies in 10 people waiting for a heart transplant. High antibodies can make it hard to find a matching donor. The goal is to help more patients become eligible for transplant.
Matched conditions: CARDIAC TRANSPLANT
Phase: PHASE2 • Sponsor: Barry A. Boilson • Aim: Disease control
Last updated May 26, 2026 11:15 UTC
-
Hearts from hepatitis c donors could expand transplant options for patients in need
Disease control OngoingThis study tests whether hearts from donors with hepatitis C can be safely given to people without hepatitis C who need a heart transplant. Twenty adults with end-stage heart failure on the transplant waiting list will receive such hearts and be treated with antiviral medication …
Matched conditions: CARDIAC TRANSPLANT
Phase: PHASE2 • Sponsor: Mary E. Keebler, MD • Aim: Disease control
Last updated May 15, 2026 11:53 UTC